Vitamin D status and weight loss: A systematic review and meta-analysis of randomized and nonrandomized controlled weight-loss trials

American Journal of Clinical Nutrition

Volumn 104, Issue 4, 2016, Pages 1151-1159

  Mallard, Simonette R ^a   Howe, Anna S ^a   Houghton, Lisa A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Meta analysis; Obesity; Serum 25 hydroxyvitamin D; Vitamin D; Weight loss

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN;

AGE; ARTICLE; BODY MASS; CALORIC RESTRICTION; CONTROLLED CLINICAL TRIAL (TOPIC); DOSE RESPONSE; EXERCISE; HUMAN; OBESITY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WEIGHT CONTROL; WEIGHT REDUCTION; ADULT; AGED; ANALOGS AND DERIVATIVES; BLOOD; BODY WEIGHT MAINTENANCE; COMPARATIVE STUDY; COMPLICATION; DIETARY SUPPLEMENT; FEMALE; MALE; META ANALYSIS; MIDDLE AGED; PHYSIOLOGY; VITAMIN D DEFICIENCY;

ADIPOSITY; ADULT; AGED; BODY WEIGHT MAINTENANCE; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS; WEIGHT LOSS;

EID: 84990046254     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.116.136879     Document Type: Article

References (57)

1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766-81.
2. Earthman CP, Beckman L, Masodkar K, Sibley S. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes (Lond) 2012;36:387-96.
3. Chandler PD, Wang L, Zhang X, Sesso H, Moorthy M, Obi O, Lewis J, Prince R, Danik J, Manson J, et al. Effect of vitamin D supplementation alone or with calcium on adiposity measures: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev 2015;73: 577-93.
4. Pathak K, Soares MJ, Calton EK, Zhao Y, Hallett J. Vitamin D supplementation and body weight status: a systematic review and metaanalysis of randomized controlled trials. Obes Rev 2014;15:528-37.
5. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 2014;348:g2035.
6. Pittas AG, Chung M, Trikalinos Y, Mitri J, Brendel M, Patel K, Lichtenstein AH, Lau J, Balk EM. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010;152:307-14.
7. Jamka M, Wozniewicz M, Jeszka J, Mardas M, Bogdański P, Stelmach- Mardas M. The effect of vitamin D supplementation on insulin and glucose metabolism in overweight and obese individuals: systematic review with meta-analysis. Sci Rep 2015;5:16142.
8. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, Cooper JD, Dastani Z, Li R, Houston DK, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013;10:e1001383.
9. Ye Z, Sharp SJ, Burgess S, Scott RA, Imamura F, InterAct Consortium, Langenberg C, Wareham NJ, Forouhi NG. Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol 2015;3:35-42.
10. Leong A, Rehman W, Dastani Z, Greenwood C, Timpson N, Langsetmo L, Berger C, METASTROKE, Fu L, Wong B, et al. The causal effect of vitamin D binding protein (DBP) levels on calcemic and cardiometabolic diseases: a Mendelian randomization study. PLoS Med 2014;11: e1001751.
11. Drincic AT, Armas LA, Van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring) 2012;20:1444-8.
12. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-3.
13. Mason C, Xiao L, Imayama I, Duggan CR, Bain C, Foster-Schubert KE, Kong A, Campbell KL, Wang C-Y, Neuhouser ML, et al. Effects of weight loss on serum vitamin D in postmenopausal women. Am J Clin Nutr 2011;94:95-103.
14. Ceglia L, Nelson J, Ware J, Alysandratos K-D, Bray G, Garganta C, Nathan D, Hu F, Dawson-Hughes B, Pittas A, et al. Association between body weight and composition and plasma 25-hydroxyvitamin D level in the Diabetes Prevention Program. Eur J Nutr 2015 Nov 2 (Epub ahead of print; DOI: 10.1007/s00394-015-1066-z).
15. Muldowney S, Walsh E, Walton J, McNulty B, Nugent A, Gibney MJ, Flynn A, Cashman KD. Vitamin D status in a representative sample of Irish adults aged $18 years. Proc Nutr Soc 2011;69:E386.
16. Brouwer DA, van Beek J, Ferwerda H, Brugman A, van der Klis F, van der Heiden H, Muskiet F. Rat adipose tissue rapidly accumulates and slowly releases an orally-administered high vitamin D dose. Br J Nutr 1998;79:527-32.
17. Barker T, Henriksen V, Martins T, Hill H, Kjeldsberg C, Schneider E, Dixon B, Weaver L. Higher serum 25-hydroxyvitamin D concentrations associate with a faster recovery of skeletal muscle strength after muscular injury. Nutrients 2013;5:1253-75.
18. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
19. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
20. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions [Internet]. Version 5.1.0. The Cochrane Collaboration; 2011 [cited 2016 Jan 12]. London: The Cochrane Collaboration. Available from: http://handbook.cochrane.org/ (accessed 12 January 2016).
21. Riedt CS, Cifuentes M, Stahl T, Chowdhury HA, Schlussel Y, Shapses SA. Overweight postmenopausal women lose bone with moderate weight reduction and 1 g/day calcium intake. J Bone Miner Res 2005;20:455-63.
22. Cifuentes M, Riedt CS, Brolin RE, Field MP, Sherrell RM, Shapses SA. Weight loss and calcium intake influence calcium absorption in overweight postmenopausal women. Am J Clin Nutr 2004;80:123-30.
23. Jones KS, Assar S, Vanderschueren D, Bouillon R, Prentice A, Schoenmakers I. Predictors of 25(OH)D half-life and plasma 25(OH)D concentration in The Gambia and the UK. Osteoporos Int 2015;26:1137-46.
24. Johnston BC, Kanters S, Bandayrel K, Wu P, Naji F, Siemieniuk RA, Ball GD, Busse JW, Thorlund K, Guyatt G, et al. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA 2014;312:923-33.
25. Young DS, Huth EJ. SI units for clinical measurement. Philadelphia: American College of Physicians; 1998.
26. World Health Organization Expert Committee on Biological Standardization. Report of the Subcommittee on Fat-Soluble Vitamins. London: World Health Organization; 1949.
27. Thibault V, Morisset A-S, Brown C, Carpentier AC, Baillargeon J-P, Langlois M-F, Gagnon C. The increase in serum 25-hydroxyvitamin D following weight loss does not contribute to the improvement in insulin sensitivity, insulin secretion and beta-cell function. Br J Nutr 2015;114:161-8.
28. Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS, Hahn S, Jang BH, Son HJ. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol 2013;66:408-14.
29. Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, Nasser M, Meerpohl J, Post PN, Kunz R, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 2013;66:719-25.
30. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997;315:629-34.
31. Baker WL, White CM, Cappelleri JC, Kluger J, Coleman CI, Health Outcomes Policy and Economics (HOPE) Collaborative Group. Understanding heterogeneity in meta-analysis: the role of meta-regression. Int J Clin Pract 2009;63:1426-34.
32. Shah K, Armamento-Villareal R, Parimi N, Chode S, Sinacore DR, Hilton TN, Napoli N, Qualls C, Villareal DT. Exercise training in obese older adults prevents increase in bone turnover and attenuates decrease in hip bone mineral density induced by weight loss despite decline in bone-active hormones. J Bone Miner Res 2011;26:2851-9.
33. Villareal DT, Fontana L, Das SK, Redman L, Smith SR, Saltzman E, Bales C, Rochon J, Pieper C, HuangM, et al. Effect of two-year caloric restriction on bone metabolism and bone mineral density in non-obese younger adults: a randomized clinical trial. J Bone Miner Res 2016;31:40-51.
34. Pop LC, Sukumar D, Tomaino K, Schlussel Y, Schneider SH, Gordon CL, Wang X, Shapses SA. Moderate weight loss in obese and overweight men preserves bone quality. Am J Clin Nutr 2015;101:659-67.
35. Reinehr T, de Sousa G, Alexy U, Kersting M, Andler W. Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 2007;157:225-32.
36. Ricci TA, Heymsfield SB, Pierson RN Jr., Stahl T, Chowdhury HA, Shapses SA. Moderate energy restriction increases bone resorption in obese postmenopausal women. Am J Clin Nutr 2001;73:347-52.
37. Riedt CS, Schlussel Y, von Than N, Ambia-Sobhan H, Stahl T, Field MP, Sherrell RM, Shapses SA. Premenopausal overweight women do not lose bone during moderate weight loss with adequate or higher calcium intake. Am J Clin Nutr 2007;85:972-80.
38. Rock CL, Emond JA, Flatt SW, Heath DD, Karanja N, Pakiz B, Sherwood NE, Thomson CA. Weight loss is associated with increased serum 25-hydroxyvitamin D in overweight or obese women. Obesity (Silver Spring) 2012;20:2296-301.
39. Shapses SA, Von Thun NL, Heymsfield SB, Ricci TA, Ospina M, Pierson RN Jr., Stahl T. Bone turnover and density in obese premenopausal women during moderate weight loss and calcium supplementation. J Bone Miner Res 2001;16:1329-36.
40. Shapses SA, Sukumar D, Schneider SH, Schlussel Y, Sherrell RM, Field MP, Ambia-Sobhan H. Vitamin D supplementation and calcium absorption during caloric restriction: a randomized double-blind trial. Am J Clin Nutr 2013;97:637-45.
41. Shea KL, Gozansky WS, Sherk VD, Swibas TA, Wolfe P, Scherzinger A, Stamm E, Kohrt WM. Loss of bone strength in response to exerciseinduced weight loss in obese postmenopausal women: results from a pilot study. J Musculoskelet Neuronal Interact 2014;14:229-38.
42. Pannu PK, Zhao Y, Soares MJ. Reductions in body weight and percent fat mass increase the vitamin D status of obese subjects: a systematic review and metaregression analysis. Nutr Res 2016;36:201-13.
43. Mawer EB, Backhouse J, Holman CA, Lumb GA, Stanbury SW. The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci 1972;43:413-31.
44. Didriksen A, Burild A, Jakobsen J, Fuskevag OM, Jorde R. Vitamin D-3 increases in abdominal subcutaneous fat tissue after supplementation with vitamin D-3. Eur J Endocrinol 2015;172:235-41.
45. Rosenstreich SJ, Rich C, Volwiler W. Deposition in and release of vitamin D3 from body fat: evidence for a storage site in the rat. J Clin Invest 1971;50:679-87.
46. Rubin DB. Estimating causal effects of treatments in randomized and nonrandomized studies. J Educ Psychol 1974;66:688-701.
47. Ioannidis JP, Haidich AB, Pappa M, Pantazis N, Kokori SI, Tektonidou MG, Contopoulos-Ioannidis DG, Lau J. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 2001;286:821-30.
48. Saneei P, Salehi-Abargouei A, Esmaillzadeh A. Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review and meta-analysis. Obes Rev 2013;14:393-404.
49. Hirani V, Mosdøl A, Mishra G. Predictors of 25-hydroxyvitamin D status among adults in two British national surveys. Br J Nutr 2009; 101:760-4.
50. New Zealand Ministry of Health. Vitamin D status of New Zealand adults: findings from the 2008/9 New Zealand Adult Nutrition Survey. Wellington (New Zealand): New Zealand Ministry of Health; 2012.
51. Arner P, Bernard S, Salehpour M, Possnert G, Liebl J, Steier P, Buchholz BA, Eriksson M, Arner E, Hauner H, et al. Dynamics of human adipose lipid turnover in health and metabolic disease. Nature 2011;478:110-3.
52. Mason C, Xiao L, Imayama I, Duggan C, Wang CY, Korde L, McTiernan A. Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial. Am J Clin Nutr 2014;99: 1015-25.
53. Wamberg L, Kampmann U, Stødkilde-Jørgensen H, Rejnmark L, Pedersen SB, Richelsen B. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels - results from a randomized trial. Eur J Intern Med 2013;24:644-9.
54. Jorde R, Sneve M, Torjesen P, Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2010;267: 462-72.
55. Wamberg L, Pedersen SB, Rejnmark L, Richelsen B. Causes of vitamin D deficiency and effect of vitamin D supplementation on metabolic complications in obesity: a review. Curr Obes Rep 2015;4: 429-40.
56. Dietz WH, Baur LA, Hall K, Puhl RM, Taveras E, Uauy R, Kopelman P. Management of obesity: improvement of health-care training and systems for prevention and care. Lancet 2015;385:2521-33.
57. Swinburn B, Kraak V, Rutter R, Vandevijvere S, Lobstein T, Sacks G, Gomes F, Marsh T, Magnusson R. Strengthening of accountability systems to create healthy food environments and reduce global obesity. Lancet 2015;385:2534-45.